Hydrogenious, a technology provider based in Erlangen, Germany, has successfully raised over €17 million in a financing round involving prominent investors like AP Ventures, Temasek, Winkelmann Group, and others. This funding will support the company's flagship projects such as the industrial-scale LOHC hydrogenation plant at Chempark Dormagen and the 'Green Hydrogen @ Blue Danube' project. The company has undergone a strategic realignment, with Dr. Daniel Teichmann transitioning to the role of Executive Chairman of the Board of Directors. The management team has also been strengthened with key appointments like Dr. Andreas Lehmann as Chief Executive Officer and Dr. Caspar Paetz as Chief Technology Officer. Dr. Stefan Buerkle has joined as the Chief Operating Officer, bringing extensive experience in the energy industry. The company's focus on LOHC technology aligns with political and financial support, as evidenced by a significant grant from the German Federal Government and the State of Bavaria. Stakeholders like AP Ventures, Anglo American Platinum, and Winkelmann Group express confidence in Hydrogenious' ability to drive the hydrogen economy and facilitate the energy transition. The company's strategic realignment and emphasis on industrial-scale projects position them as a market leader in hydrogen technology.